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Tissue inhibitor of metalloproteinases (TIMP) from cultured bovine dental pulp inhibits human rheumatoid synovial ma-
trix metalloproteinase 3 (MMP-3) with a stoichiometry of 1: 1 on a molar basis. Among the serine proteinases examined, 
human neutrophil elastase, trypsin and a-chymotrypsin destroyed the inhibitory activity of TIMP against MMP-3 by 
degrading the inhibitor molecule into small fragments. In contrast, the inhibitory activity of TIMP was not significantly 
reduced by the actions of cathepsin G, pancreatic elastase and plasmin. These data indicate that neutrophils which infil- 
trate tissues in various inflammatory conditions may play an important role in regulating TIMP activity in vivo through 
the action of neutrophil elastase. 
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1. INTRODUCTION cells, also produce a specific inhibitor to these 
MMPs called tissue inhibitor of metalloproteinases 
Human rheumatoid synovial cells in culture (TIMP) [7,8]. Thus, the balance between the ac-
secrete at least three distinct metalloproteinases, all tivities of tissue metalloproteinases and TIMP is 
of which are capable of degrading extracellular thought to be an important determinant of 
matrix components [11. We have referred to them whether MMPs participate in extracellular matrix 
as matrix metalloproteinases (MMPs): MMP-1 breakdown in vivo. Here, we have examined the 
corresponds to collagenase [2], MMP-2 to effect of serine proteinases on a metalloproteinase 
gelatinase [3,4] and MMP-3 to a third enzyme inhibitor from bovine dental pulp which has 
which digests proteoglycans, type IV collagen, properties typical of TIMP. We report that its in- 
laminin and fibronectin [l]. The properties of hibitory activity against human MMP-3 is 
MMP-3 purified from human rheumatoid synovial destroyed by human neutrophil elastase as well as 
cells in culture are essentially identical to those trypsin and cu-chymotrypsin. 
described for the metalloproteinase purified from 
culture media of rabbit bone explants called ‘pro-
2. MATERIALS AND METHODSteoglycanase’ [5] and of rabbit synovial fibroblasts 
termed ‘stromelysin’ [6]. On the other hand, con- 2.1. Materials 
nective tissue cells, including rheumatoid synovial TIMP was purified from the culture medium of bovine dental 
pulp as reported [9]. Two active forms of MMP-3 (&fr 28000 
and 45000) were purified from the medium of rheumatoid 
Correspondence address: Y. Okada, Department of Pathology, synovial cells treated with rabbit macrophage-conditioned 
School of Medicine, Kanazawa University, 13-l Takara-machi, medium [I]. Both the inhibitor and MMP-3 were homogeneous 
Kanazawa 920, Japan according to SDS-polyacrylamide gel electrophoresis (SDS-
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Fig. 1. Inhibition of MMP3 by the inhibitor from bovine dental 
pulp. A fixed amount of active low-M, MMP-3 (MI 28000) or 
high-M, MMP-3 (Mr 45000) was incubated with inhibitor at 
various molar ratios and residual activity of MMP-3 then 
assayed at 37°C for 1.5 h using t3H]Cm-Tf as substrate. 
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Fig.2. Effects of serine proteinases on TIMP activity against 
MMP-3. TIMP was incubated with (a) bovine trypsin, (b) 
bovine cy-chymotrypsin, (c) human neutrophil elastase, (d) 
human neutrophil cathepsin G, (e) porcine pancreatic elastase, 
and (f) human plasmin at various concentrations (0, 1; 0, 10; 
i , 50; A , lOO~g/ml). After inactivating the serine 
proteinases, a 1.1 molar excess of MMP-3 was added to 
mixtures and residual enzymic activity of MMP-3 assayed. The 
inhibitory activity of TIMP obtained from samples incubated in 
the absence of serine proteinases was taken as 100% activity. 
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Fig.3. Degradation of TIMP by human neutrophil elastase. A 
mixture of unlabeled and ‘ZSI-labeled TIMP was incubated with 
neutrophil elastase (10 gg/ml). Samples were subjected on SDS- 
PAGE (12.5% total acrylamide) in (a) the presence and (b) the 
absence of 2-mercaptoethanol and the gels autoradiographed. 
Lanes: 1,5, TIMP incubated without enzyme for 0 and 24 h; 
2-4, TIMP treated with the enzyme for 4, 9 and 24 h, 
respectively. M, values (x 10W3) given to the left of the gels. 
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Fig.4. Digestion of TIMP by human neutrophil cathepsin G. A 
mixture of unlabeled and ‘Z51-labeled TIMP was treated with 
neutrophil cathepsin G (10 /rg/ml) and analyzed by SDS-PAGE 
as described in the legend to fig.3. M, values (x 10m3) given to 
the left. 
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PAGE). MMP-1 free from MMP-2 and MMPJ was obtained 
by removing each contaminating component by chromatog- 
raphy on affi-gel-gelatin and anti-(MMP?) IgG-Sepharose, 
respectively. MMP-2 free from MMP-1 and MMP-3 was 
prepared using immunoadsorbent columns of anti-
(MMP-1)IgG and anti-(MMP-3)IgG coupled to Sepharose. 
Bovine Tos-Phe-CHr-Cl-treated trypsin, cu-chymotrypsin, 
human plasminogen, streptokinase, bovine thrombin, porcine 
pancreatic elastase and diisopropyl fluorophosphate were ob-
tained from Sigma. Plasma kallikrein was purified according to 
Nagase and Barrett [lo]. Plasminogen was activated to plasmin 
by streptokinase. Human leukocyte elastase (1 l] and cathepsin 
G [12] were purified as described. 
2.2. Inhibition of MMP-I, -2 and -3 activities by bovine dental 
pulp inhibitor 
The activities of MMP-l-3 were assayed as in [l] using 
[‘4C]collagen, [i4C]gelatin and [3H]carboxymethylated trans-
ferrin ([‘H]Cm-Tf) as substrates for MMP-1, MMP-2 and 
MMP-3, respectively. The inhibitory activity of the bovine den- 
tal pulp inhibitor against metalloproteinases was determined by 
measuring the residual enzymic activity after incubating enzyme 
with inhibitor for 1 h at 23°C. 
2.3. Degradation of TIMP by serine proteinases 
Inactivation of TIMP by serine proteinases was investigated 
as follows: TIMP (68 ng) in 10~1 of 50 mM Tris-HCl, pH 7.6, 
0.15 M NaCl, 10 mM Ca’+, 0.02% NaNp was initially reacted 
with an equal volume of trypsin (1, 10, SOrg/ml), (Y-
chymotrypsin (1, 10, 50 pg/ml), human neutrophil elastase (1, 
lo,50 fig/ml), human neutrophil cathepsin G (1, lo,50 pg/ml), 
porcine pancreatic elastase (10, 50, 100 pg/ml), human plasma 
plasmin (10, 50, lOOgg/ml), human plasma kallikrein (1, 
10 pg/ml) or bovine thrombin (10, 50, 100 pg/ml) at 37°C for 
2-26 h. After blocking the activity of the serine proteinases 
with 3.3 mM diisopropyl fluorophosphate, a 1.1 molar excess 
of MMP-3 (Mr 28600, 75 ng) was added to the mixtures and in- 
cubation performed for 1 h at 23°C. The residual enzymic ac-
tivity of MMP-3 was determined by incubation with [3H]Cm-Tf 
for 1.5 h at 37°C. 
2.4. Electrophoretic analyses of M, changes of TIMP 
TIMP (11 rg) was radioiodinated according to Fraker and 
Speck [13]. A mixture containing unlabeled TIMP (60 ng) and 
1251-labeled inhibitor (8 ng) was treated with trypsin (1, 
lOpg/ml), cu-chymotrypsin (1, 10 rg/ml), human neutrophil 
elastase (1, 10, 50 pg/ml), human neutrophil cathepsin G (10, 
50, 100 @g/ml), porcine pancreatic elastase (10, 50, 100 pg/ml), 
human plasma plasmin (10, 50, lOO,~g/ml), human plasma 
kallikrein (1, 10, 20rg/ml) or bovine thrombin (10, 50, 
lOObg/ml) at 37°C for 4-24 h. After the incubation, the serine 
proteinases were inactivated using 4 mM diisopropyl 
fluorophosphate. Proteins in the samples were resolved by SDS- 
PAGE using 12.5% polyacrylamide gels with or without reduc-
tion with 2-mercaptoethanol. Gels were dried and 
autoradiographed. 
3. RESULTS AND DISCUSSION 
The inhibitor from bovine dental pulp showed 
dose-dependent inhibition of MMP-1 and MMP-2 
from human rheumatoid synovial cells (not 
shown). Fig. 1 illustrates the 1: 1 molar 
stoichiometric inhibition of two active forms of 
MMP-3. The same 1: 1 ratio of stoichiometric in-
hibition has been reported for collagenase and 
TIMP purified from culture medium of rabbit 
bone [7] and human skin fibroblasts [14]. The 
bovine dental pulp inhibitor used here was con-
sidered to be TIMP according to the following 
criteria: (i) it is a sialoglycoprotein with MI 28000 
and is heat-stable, but is destroyed by reduction 
and alkylation [9,15]; (ii) it inhibits MMP-1-3 
from human rheumatoid synovial cells (this study) 
as well as various other animal collagenases [16]; 
(iii) monoclonal antibodies raised against the in-
hibitor show cross-reactivity to TIMP purified 
from human gingival fibroblasts [17]; and (iv) it 
contains six disulfide linkages [9] and the sequence 
of 45 amino acids at the NHz-terminus (unpublish-
ed) is 91% identical to that of human TIMP de-
duced from its cDNA [ 181. 
The inhibitory activity of TIMP against MMP-3 
was almost completely abolished by reacting the 
inhibitor with relatively low concentrations of 
trypsin, cu-chymotrypsin and neutrophil elastase 
(fig.2). Cathepsin G and pancreatic elastase show-
ed some degradative effects on the inhibitor but 
higher concentrations were required for partial in-
activation (fig.2). However, plasmin (fig.2), 
plasma kallikrein and thrombin had no effect even 
at lOOpg/ml (not shown). 
TIMP treated with human neutrophil elastase 
(10 ,ug/ml) was converted into forms with M, 
17000 and 16000. These were further degraded in-
to small fragments on prolonged incubation 
(fig.3). However, under non-reducing conditions, 
the polypeptides of M, 17 000 and 16000 were not 
detected, but there was a time-dependent disap-
pearance of the band corresponding to native 
TIMP (fig.3). These results indicate that the 
polypeptides of M, 17 000 and 16 000 correspond to 
disulfide-linked fragments of nicked TIMP of iWr 
28000; after prolonged incubation the inhibitor 
was degraded into smaller inactive fragments. 
Similar findings were made with trypsin and cy-
chymotrypsin except that the two fragments 
generated were of M, 18000 and 14000. 
Human neutrophil cathepsin G (fig.4), porcine 
pancreatic elastase and human plasma plasmin 
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also processed TIMP and produced two ma­
jor polypeptides of Mr 18000-19000 and 
13000-14000 (not shown). However, the unre­
duced samples showed no evidence of the disap­
pearance of TIMP of Mr 28000 (fig.4) and the 
decrease in inhibitory activity was minimal (fig.2). 
These observations suggest that in some cases 
TIMP retains its inhibitory activity even after 
limited proteolysis if the processed polypeptides re­
main linked via disulfide bonds, presumably in 
such a way as to retain the correct conformation of 
the inhibitor molecule. 
It has been reported that the inhibitory activity 
of TIMP isolated from culture media of bone ex­
plants and fibroblasts [7,19] or from extracts of ar­
ticular cartilage [20] is sensitive to trypsin. The 
present study has shown for the first time that 
human neutrophil elastase and a-chymotrypsin 
can also abolish the metalloproteinase inhibitory 
capacity of TIMP. It is clear from our study that 
these serine proteinases inactivate TIMP by achiev­
ing its proteolytic degradation. Similar proteolytic 
inactivation has also been reported for plasma 
serine proteinase inhibitors, for example, 
aI-proteinase inhibitor by Pseudomonas aeru­
ginosa elastase [21] and antithrombin by 
neutrophil elastase [22]. 
Matrix metalloproteinases are able to digest 
most extracellular matrix components including 
collagen types I, II, III, IV, V and X, pro­
teoglycans, laminin and fibronectin [1-6,23]. We 
have observed, using indirect immuno­
fluorescence, that MMP-1 and MMP-3 are syn­
thesized and secreted by hyperplastic synovial 
lining (intima) cells of human rheumatoid 
synovium (in preparation). It is envisaged that for 
activated metalloproteinases to carry out a destruc­
tive function in rheumatoid joints, they must be 
present in sufficient quantities to exhaust the in­
hibitory activity of TIMP present in articular car­
tilage [20] and secreted from synovial cells [24]. 
Our present results suggest that neutrophils which 
have penetrated the joint space during the inflam­
matory stage of rheumatoid arthritis [25] may in­
directly participate in joint destruction. The 
potentiation of metalloproteinase activity through 
inactivation of TIMP, as proposed here, does not 
preclude the possibility of direct proteolysis of ex­
tracellular matrix components by elastase and 
other neutrophil enzymes. 
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